Premium
Repair of rat critical size calvarial defect using osteoblast‐like and umbilical vein endothelial cells seeded in gelatin/hydroxyapatite scaffolds
Author(s) -
Johari Behrooz,
Ahmadzadehzarajabad Maryam,
Azami Mahmoud,
Kazemi Mansure,
Soleimani Mansooreh,
Kargozar Saied,
Hajighasemlou Saieh,
Farajollahi Mohammad M,
Samadikuchaksaraei Ali
Publication year - 2016
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.35710
Subject(s) - materials science , scaffold , calvaria , umbilical vein , biomedical engineering , gelatin , osteoblast , tissue engineering , in vitro , chemistry , medicine , biochemistry
The present study used a previously developed three‐dimensional Gelatin/Hydroxyapatite (Gel/HA) homogeneous nanocomposite scaffold with porosity of 82% and interconnecting pores ranging from 300 to 500 μm. Cell‐seeded scaffolds were used to evaluate bone regeneration of rat critical‐size calvarial defect. Totally, 36 male Wistar rats were randomly divided into four experimental groups, including blank defect (defects without any graft), blank scaffold (defects filled with Gel/HA scaffold without cells), and two groups of cell‐seeded scaffolds (defects filled with either Gel/HA scaffold seeded with osteoblast‐like and endothelial cells or osteoblast‐like cell‐seeded constructs). After 1, 4, and 12 weeks of scaffold implantation, rats were sacrificed and the calvaria were harvested for histological, immunohistochemical and histomorphometric analysis. In vitro tests showed that scaffolds were nontoxic to cells and promoted ideal cellular attachment. In vivo investigation on scaffold revealed that blank calvarial defects indicated incomplete tissue coverage and little evidence of bone healing. However, blank scaffold and cell‐seeded scaffolds significantly promoted osteoconduction and ostegogenesis. Taken together, pre‐seeded Gel/HA nanocomposite scaffold with osteoblasts and endothelial cells presented an effective combination to improve osteogenesis in the engineered bone implant. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1770–1778, 2016.